Investors
Corporate Governance
Alnylam employees, officers, and directors are held to high standards set by
our Board of Directors.
These standards and procedures can be found in the following guidelines.
Governance Guidelines
container-970 d-flex flex-1
Third Party Code of
Conduct
Download PDF
Code of Business Conduct
and Ethics
Download PDF
Comprehensive
Compliance Program
Download PDF
Corporate Governance
Guidelines
Download PDF
Responsible Use of
Artificial Intelligence (AI)
Download PDF
Human Rights Principles
Download PDF
Charters
| Type | View/Download |
|---|---|
| Nominating and Corporate Governance Committee Charter | |
| People, Culture and Compensation Committee | |
| Audit Committee Charter | |
| Science and Technology Committee Charter |
Executive Leadership Team
We have passionate leaders from the biopharmaceutical industry who bring
together their experiences
of drug discovery, drug development, and commercialization.
Yvonne Greenstreet, MD, MBA
Chief Executive Officer
Kevin Fitzgerald, PhD
Chief Scientific Officer
Pushkal Garg, MD
Chief Research and Development Officer
Christine Akinc
Chief Corporate Communications Officer
Timothy Maines
Chief Technical Operations and Quality Officer
Melissa McLaughlin, MBA
Chief Human Resources Officer
Jeff Poulton, MBA
Chief Financial Officer
Piyush Sharma, JD
Chief Ethics & Compliance Officer
Bryan Supran, JD
Chief Legal Officer
Tolga Tanguler, MBA
Chief Commercial Officer
Board of Directors
We have a team of accomplished leaders from various backgrounds who elevate our initiatives and strategies.
Chair of the Board: Amy W. Schulman
Audit Committee
Olivier Brandicourt, M.D.
Peter N. Kellogg, Chair
Colleen
Reitan
Created to assist the Board of Directors’ oversight of the Company’s accounting and financial reporting processes and the audits of the Company’s financial statements.
People, Culture and Compensation Committee
Stuart A. Arbuckle
Olivier Brandicourt, M.D.
Colleen Reitan, Chair
Amy W. Schulman
Elliott Sigal, M.D. Ph.D
Designed to assist the Board of Directors in the discharge of its responsibilities relating to compensation of the Company’s executive officers.
Nominating and Corporate Governance Committee
Stuart A. Arbuckle
Dennis A. Ausiello, M.D.
Margaret A. Hamburg, M.D.
David E.I. Pyott, Chair
Amy W. Schulman
Recommends to the Board the persons to be nominated for election as directors at any meeting of stockholders; develop and recommend to the Board a set of corporate governance principles applicable to the Company; and oversee the evaluation of the Board.
Science and Technology Committee
Dennis A. Ausiello, M.D.
Elliott Sigal, M.D. Ph.D, Chair
Assists the Board’s oversight of the Company’s research and development activities and to advise the Board with respect to strategic and tactical scientific issues.
Looking for specific information that isn't listed above?
Contact: investors@alnylam.com
FOLLOW US
